Generali Investments Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Generali Investments Management's IDXX Position: Q2 2026 in Review
Generali Investments Management increased its Idexx Laboratories (IDXX) stake by 41% in Q2 2026, buying an estimated $147K and bringing the position to 902 shares worth $475K. The position accounts for 0.1% of the portfolio, ranked #112.
Generali Investments Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $731K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Generali Investments Management held 902 shares of Idexx Laboratories worth $475K as of Q2 2026.
- Generali Investments Management bought 262 Idexx Laboratories shares in Q2 2026, an estimated $147K.
- Idexx Laboratories made up 0.1% of Generali Investments Management's portfolio in Q2 2026, its #112 holding.
- Generali Investments Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
- Generali Investments Management's Idexx Laboratories position peaked at $731K in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.